A new study from Columbia University, published in Cancer Epidemiology, Biomarkers & Prevention on July 1, 2025, has raised serious concerns about the rising ...
The global lung cancer treatment market is expanding quickly, thanks to better treatments and growing awareness. In 2024, the market reached $32.64 billion, and ...
Regeneron Pharmaceuticals has received a big thumbs-up from the US Food and Drug Administration (FDA) for its new blood cancer drug called Lynozyfic. This ...
In a positive development for cancer patients, Memorial Sloan Kettering Cancer Center (MSK) and UnitedHealthcare (UHC) have announced a new, multiyear agreement ensuring continued ...
Uterine cancer cases in the United States are projected to rise sharply by 2050, with Black women facing disproportionately higher risks, including a threefold ...
The U.S. Food and Drug Administration (FDA) has approved 13 new oncology treatments between April 1 and June 30, 2025. These approvals introduce novel ...
In a major development for cancer patients, UnitedHealthcare and Memorial Sloan Kettering Cancer Center (MSK) announced on Tuesday that they had reached a multi-year ...
In a groundbreaking study led by Prof. Smita Krishnaswamy from Yale, a multinational team of researchers has developed an advanced AI tool called AAnet. ...
